XML 85 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
Collaboration, License, and Other Agreements - North America - Collaborative Arrangements Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:                      
Revenue $ 117,553 $ 113,739 $ 107,382 $ 104,061 $ 107,199 $ 108,637 $ 97,231 $ 97,529 $ 442,735 $ 410,596 $ 413,753
Collaborative arrangements revenue                      
Revenues:                      
Revenue                 442,735 410,596 412,784
AbbVie Plc | North America | Collaborative arrangements revenue                      
Revenues:                      
Revenue                 433,242 401,498 403,085
AbbVie Plc | North America | Collaborative arrangement, collaboration and license agreements                      
Revenues:                      
Revenue                 433,242 401,498 403,085
AbbVie Plc | North America | Collaborative arrangements, LINZESS                      
Revenues:                      
Revenue                 430,463 398,767 400,371
AbbVie Plc | North America | Royalty                      
Revenues:                      
Revenue                 $ 2,779 $ 2,731 $ 2,714